HCA Healthcare Financials - Benzinga

HCA Healthcare Inc

HCANYSE

Trade with Public

Trade with Public

$417.76

3.310.8%

Ult. Agg.: Sep 1, 9:19 AM

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzoDati finanziariSentiment Azionariato Dividendi Confronta Opzioni Rapporto azionario

HCA Healthcare Financials

HCA Healthcare (HCA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Behind HCA's Q2 Beat: One-Time Medicaid Boost and a Growing Insurance Headwind

HCA's Q2 results beat expectations. Company resets 2026 guidance on HIX headwinds and decline in surgeries.

Priya Nigam

HCA Healthcare Analysts Slash Their Forecasts After Q2 Results

HCA Healthcare's Q2 earnings beat expectations with $20.23B in revenue and adjusted earnings of $7.59 per share. Analysts lower price targets.

Avi Kapoor

HCA Healthcare Surpasses Q2 Estimates With Strong Admissions Growth

HCA Healthcare beat Q2 revenue and earnings estimates as admissions rose, while a payer mix shift and lower surgical volumes weighed on results.

Vandana Singh

PRO
HCA Healthcare Affirms FY2026 GAAP EPS Guidance of $28.70-$30.50 vs $29.70 Est; Affirms FY2026 Sales Guidance of $77.000B-$79.500B vs $78.457B Est

HCA Healthcare (NYSE:HCA) affirms FY2026 GAAP EPS guidance from $28.70-$30.50 to $28.70-$30.50 vs $29.70 analyst estimate. Affirms FY2026 sales outlook from $77.000 billion-$79.500 billion to $77.000 billion-$79.500

Benzinga Newsdesk

PRO
HCA Healthcare Q2 Adj. EPS $7.59 Beats $7.02 Estimate, Sales $20.230B Beat $19.400B Estimate

HCA Healthcare (NYSE:HCA) reported quarterly earnings of $7.59 per share which beat the analyst consensus estimate of $7.02 by 8.12 percent. This is a 10.96 percent increase over earnings of $6.84 per share from the

Benzinga Newsdesk

Earnings Scheduled For July 24, 2026

Companies Reporting Before The Bell • Charter Communications (NASDAQ:CHTR) is likely to report quarterly earnings at $10.19 per share on revenue of $13.53 billion. • American Express (NYSE:AXP) is expected to report

Benzinga Insights

© 2026 Benzinga | All Rights Reserved